Foresite Capital Opportunity Management V as of March 31, 2022
Portfolio Holdings for Foresite Capital Opportunity Management V
Foresite Capital Opportunity Management V holds 10 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 52.8 | $38M | 5.2M | 7.22 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 10.5 | $7.5M | 1.6M | 4.68 | |
| Theseus Pharmaceuticals | 7.6 | $5.4M | 469k | 11.53 | |
| Cue Health (HLTHQ) | 5.8 | $4.1M | 642k | 6.45 | |
| Cullinan Oncology (CGEM) | 4.9 | $3.5M | 331k | 10.47 | |
| Adicet Bio (ACET) | 4.8 | $3.4M | 170k | 19.97 | |
| Gemini Therapeutics | 4.7 | $3.4M | 2.4M | 1.39 | |
| Kinnate Biopharma | 4.6 | $3.3M | 292k | 11.26 | |
| Enanta Pharmaceuticals (ENTA) | 2.3 | $1.6M | 23k | 71.16 | |
| Compass Therapeutics (CMPX) | 2.1 | $1.5M | 1.1M | 1.37 |
